Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/28/2009 | CN100554280C Plant ERF transcription factor, encoding gene and application thereof |
10/28/2009 | CN100553682C G type non-viral vector and pharmaceutical composition containing same |
10/27/2009 | USRE40948 APC antibodies |
10/27/2009 | US7610154 Method and apparatus for chemical genetic programming |
10/27/2009 | US7608763 Plants and seeds of hybrid corn variety CH100833 |
10/27/2009 | US7608762 Plants and seeds of hybrid corn variety CH788706 |
10/27/2009 | US7608759 Scarecrow-like stress-related polypeptides and methods of use in plants |
10/27/2009 | US7608758 Plant system for comprehensive gene function analysis with the use of full-length cDNA |
10/27/2009 | US7608757 Transgenic drought resistant plants; crops with enhanced resistance to enviromental stresses |
10/27/2009 | US7608756 introducing into a plant cell a chimeric gene comprising an isolated promoter region that controls epidermis-specific expression operably linked to the desired coding sequence, said promoter region comprising a first sequence originating from the promoter of a GSTA1 and 2nd from intron of a WIR1 genes |
10/27/2009 | US7608755 Used to modulate the phytic acid biosynthesis in such a way as to decrease phytate and/or increase non-phytate phosphorous, especially in corn or soy animal feedstuffs |
10/27/2009 | US7608754 Using trangenic dicots to produce trisaccharide 1-kestose with low degree of polymerization; forming low caloric sweeteners in plants |
10/27/2009 | US7608753 Nucleotide sequences coding polyunsaturated fatty acid polyketide synthase of schizochytrium for use in preparation and delivery of therapeutic pharmaceuticals for treatment of bone, neurodegenerative inflammatory and cell proliferative diseases |
10/27/2009 | US7608752 Gene targeting using replicating DNA molecules |
10/27/2009 | US7608751 Fungus resistant plants and their uses |
10/27/2009 | US7608750 Nonhuman model animal unresponsive to immunopotentiating synthetic compound |
10/27/2009 | US7608749 Monitoring APP cleavage in transgenic rodents comprising an APP Swedish mutation |
10/27/2009 | US7608708 Monocotyledon plant cells and plants which synthesize modified starch |
10/27/2009 | US7608707 siRNA targeting survivin |
10/27/2009 | US7608706 An siRNA molecule consisting of a sense region and an antisense region which together form a duplex region consisting of 19-30 base pairs and the antisense region comprises a sequence complementing SEQ ID NO: 449; having either no overhang regions or one or more; increasing the efficiency of RNAi |
10/27/2009 | US7608705 Oligonucleotides, agents containing these oligonucleotides, and the use thereof |
10/27/2009 | US7608704 Isolated polynucleotide encoding a polypeptide having preprosecretin activity and the amino acid sequence of SEQ ID NO:6; genetic engineering; cell cultures; antiproliferative agents; autoimmune diseases; antiinflammatory agents; cardiovascular/ nervous system/ developmental/gene expression disorders |
10/27/2009 | US7608703 Nucleic acid with acyl transferase activity; vectors, host cells; biosynthesis of polyunsaturated fatty acid (PUFA) |
10/27/2009 | US7608702 PUFA polyketide synthase systems and uses thereof |
10/27/2009 | US7608701 Corticotropin releasing factor 2 receptor agonists |
10/27/2009 | US7608700 Lactobacillus acidophilus nucleic acid sequences encoding stress-related proteins and uses therefor |
10/27/2009 | US7608698 Muscular disorders; cardiovascular disorders; cell transformed with nucleic acid; culture product |
10/27/2009 | US7608697 Mixture comprising enzymatic polypeptides with proline modified terminal for use in enhancing/reducing digestion/flavor/bitterness of foods; food processing |
10/27/2009 | US7608696 Immunoglobulin for use in diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions; drug screening; immunotherapy and diagnostics; anticarcinogenic agents |
10/27/2009 | US7608694 Neutralizing antibody with specificity for antigenic determinants; infections (viral, bacterial, fungal and parasitic), endotoxic shock associtated with infection, arthritis, rheumatoid arthritis, pelvic inflammatory disease, Alzheimer's Disease, Crohn's disease |
10/27/2009 | US7608691 Antibodies against IL-16 antagonist peptides |
10/27/2009 | US7608690 IL-B30 antibodies |
10/27/2009 | US7608686 Ztnfr12 polypeptides and Ztnfr12 fusion proteins |
10/27/2009 | US7608683 Human leukocyte antigen pan DR-binding peptides for use in the treatment of infections, inflammatory, autoimmune and cancer diseases; has heat shock protein that is capable of binding to MHC class II molecules |
10/27/2009 | US7608681 Methods and compositions for prolonging elimination half-times of bioactive compounds |
10/27/2009 | US7608452 Polynucleotides encoding cytokine receptor zcytor19 |
10/27/2009 | US7608451 Expression vector comprising kinase nucleotide sequence for use as tool in transformation and expression of heterologus genes in mamalian cells |
10/27/2009 | US7608450 Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics |
10/27/2009 | US7608449 Methods and compositions related to high-titer pseudotyped retroviruses |
10/27/2009 | US7608448 Plasmid for transferring genetic information into prokaryotic gene sequences/operons using directed homologous recombination |
10/27/2009 | US7608445 Increased activity and stability at increased pH and temperature |
10/27/2009 | US7608443 Lysophosphatidic acid acetyltransferases |
10/27/2009 | US7608442 Obtained from Campylobacter species; for use in synthesis of lipooligosaccharide (LOS); ganglioside biosynthesis and mimetics for treatment of nervous system disorders |
10/27/2009 | US7608437 Producing coryneform bacteria with an improved amino acid or nucleic acid productivity by introducing a mutation in a promoter sequence of biosynthesizing genes on a chromosome of a coryneform bacterium so that it is close to a consensus sequence; high yields; producing L-glutamic acid |
10/27/2009 | US7608435 Microorganism producing 5′-xanthylic acid |
10/27/2009 | US7608434 Modified at an amino acid position 41, 42, 450, or 454; greater avidity; low mobility level within the cell |
10/27/2009 | US7608432 Method for producing purine nucleoside by fermentation |
10/27/2009 | US7608431 High concentration, high average sialic acid content per EPO molecule |
10/27/2009 | US7608430 Fusion protein; multimeric protein; treating interferon gamma -related conditions |
10/27/2009 | US7608428 Polynucleotide encoding an IL-28B polypeptide |
10/27/2009 | US7608427 Encoding polypeptide covalently attached with a polyethylene glycol propionaldehyde group having anti-hepatitis C activity |
10/27/2009 | US7608426 Nucleotide sequences coding for interleukin polypeptide for use as tool in tissue repair |
10/27/2009 | US7608425 For increasing the longevity of a cell culture and permitting the increased production of recombinant proteins; culturing |
10/27/2009 | US7608424 Process for production of a recombinant protein and a fusion protein |
10/27/2009 | US7608423 Expanding the eukaryotic genetic code |
10/27/2009 | US7608422 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes |
10/27/2009 | US7608410 Method of improving T cell receptors |
10/27/2009 | US7608409 Screening assay using G-protein coupled receptor protein OT7T175 |
10/27/2009 | US7608401 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis |
10/27/2009 | US7608398 Minimally cross-hybridizing nucleotide sequences; provides of a family of molecules which is sufficiently large and where each individual member is sufficiently selective for its complement over all the other zipcode molecules |
10/27/2009 | US7608288 Caffeine fraction obtained from tea leaves and a method for inducing Agrobacterium tumefaciens-mediated genetic transformation in plants using said caffeine fraction |
10/27/2009 | US7608276 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection |
10/27/2009 | US7608273 glycoprotein cationic polypeptide as HIV vaccines; nontoxic |
10/27/2009 | US7608269 Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
10/27/2009 | US7608268 Ferritin fusion proteins for use in vaccines and other applications |
10/27/2009 | US7608257 Using a reovirus and chemotherapeutic agents to treat ras-activated neoplastic cells; proliferative disorders |
10/27/2009 | US7608255 Replication-competent anti-cancer vectors |
10/27/2009 | CA2390867C Method for the production of biopolymers with modified properties |
10/27/2009 | CA2372085C L-ribo-lna analogues |
10/27/2009 | CA2349529C Pge synthase and methods and means for modulating its activity |
10/27/2009 | CA2328904C Novel (poly)peptides which represent the epitopes of the human herpesvirus type 8 |
10/27/2009 | CA2327547C Oligonucleotides containing pyrazolo[3,4-d]pyrimidines for hybridization and mismatch discrimination |
10/27/2009 | CA2230967C Improved nucleic acid assays |
10/27/2009 | CA2226397C Genes for mutant microsomal delta-12 fatty acid desaturases and related enzymes from plants |
10/27/2009 | CA2224143C Recombinant hexose oxidase, a method of producing same and use of such enzyme |
10/27/2009 | CA2202154C Methods for drug screening |
10/27/2009 | CA2163364C Self-assembling polynucleotide delivery system comprising dendrimer polycations |
10/27/2009 | CA2148492C Bovine heat shock promoter and uses thereof |
10/27/2009 | CA2146145C Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
10/22/2009 | WO2009129549A2 Babesia microti genomic clones containing novel antigens useful in the diagnosis of babesiosis |
10/22/2009 | WO2009129544A1 Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes |
10/22/2009 | WO2009129524A2 High-throughput plasmid dna preparation |
10/22/2009 | WO2009129523A2 Compositions and methods for nucleic acid delivery |
10/22/2009 | WO2009129505A2 Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid |
10/22/2009 | WO2009129465A2 Compositions and methods for inhibiting expression of xbp-1 gene |
10/22/2009 | WO2009129424A2 Longevity-promoting effects of acetic acid and reishi polysaccharide |
10/22/2009 | WO2009129319A2 Silencing of csn5 gene expression using interfering rna |
10/22/2009 | WO2009129263A1 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase |
10/22/2009 | WO2009129250A2 Meal-time insulin analogues of enhanced stability |
10/22/2009 | WO2009129247A2 Sequence diversity generation in immunoglobulins |
10/22/2009 | WO2009129162A2 Methods and compositions for increasing plant disease resistance and yield |
10/22/2009 | WO2009128953A2 Genetic variants in a hypertension susceptibility gene stk39 and uses thereof |
10/22/2009 | WO2009128949A2 Compositions of dengue viral proteins and methods of use |
10/22/2009 | WO2009128911A2 Genetics variants associated with hiv disease restriction |
10/22/2009 | WO2009128734A1 Marker assisted identification of mammals for desired phenotypic trait |
10/22/2009 | WO2009128683A2 Method for constructing a viral genomic library from the state in which viruses are mixed with the infected hosts |
10/22/2009 | WO2009128649A2 Method of separating and purifying cellular components using non-covalent bond between cucurbituril derivative and guest compound and apparatus using the same |
10/22/2009 | WO2009128526A1 Apparatus for the identification of ribonucleic acid, method for the identification of ribonucleic acid and program and system for the identification of ribonucleic acid |
10/22/2009 | WO2009128453A1 Proliferative disease detection method |
10/22/2009 | WO2009128448A1 Novel protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same |